KATRINA TODD: Open Payments
NPI 1932712973 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 55 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $611 · 2025 $1,109
Food & beverage: $1,109
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $220 |
| Novo Nordisk Inc | 10 | $193 |
| Lilly USA, LLC | 8 | $156 |
| Abbott Laboratories | 7 | $136 |
| ABBVIE INC. | 4 | $94 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| PFIZER INC. | 4 | $75 |
| Exact Sciences Corporation | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Amgen Inc. | 2 | $38 |
Products named: AIRSUPRA, FREESTYLE LIBRE 3, MOUNJARO, Ozempic, TRELEGY ELLIPTA, UBRELVY, Saxenda, Kerendia.
Industry payments across OK — which companies pay providers there.
